Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Cansino Biologics Inc
6185Current price
28.95 HKD
-1.65 HKD (-5.39%)
Last closed
67.52 CNY
Company
www.cansinotech.com
ISIN
CNE100004BM0
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
Hong Kong Stock Exchange
Capitalization
10 860 813 897 CNY
Yield for 12 month
-23.57 %
1Y
3Y
5Y
10Y
15Y
6185
CanSino Biologics Inc. develops, manufactures, and commercializes vaccines in the People's Republic of China. The company develops Convidecia and the Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N. meningitides. It develops DTcP vaccine for infants and DTcP Booster vaccine, which are in Phase I clinical trial for addressing the weaker protection preventing pertussis after primary vaccination. In addition, it develops Tdcp Adolescent and Adult vaccine for treating pertussis; PBPV, a serotype-independent protein-based pneumococcal vaccine that is in Phase I clinical trial; PCV13i, a pneumococcal conjugate vaccine, which is in Phase I clinical trial; and TB Booster for the BCG-vaccinated population which is in Phase I clinical trial. Further, it is developing various preclinical stage products, including DTcP-Hib Combo vaccine; CS-2023 to treat meningitis; CS-2028 for treating multivalent conjugate vaccine; CS-2032 for hingles; CS-2036 to treat polio; CS-2047 for treating tetanus; and CS-2201 DTcP for combination vaccine. The company was incorporated in 2009 and is headquartered in Tianjin, the People's Republic of China. Address: 401-420, Biomedical Park, Tianjin, China, 300457
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
443.64 CNYP/E ratio
–Dividend Yield
–Current Year
+346 191 973 CNY
Last Year
+1 034 057 748 CNY
Current Quarter
+171 638 457 CNY
Last Quarter
+114 616 660 CNY
Current Year
-878 582 164 CNY
Last Year
-187 152 994 CNY
Current Quarter
+119 449 887 CNY
Last Quarter
+68 248 705 CNY
Key Figures 6185
1 year
3 years
5 years
10 years
EBITDA
-863 571 211 CNY
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-8.14 %
PEG Ratio
–
Return On Equity TTM
-13.62 %
Wall Street Target Price
443.64 CNY
Revenue TTM
750 719 611 CNY
Book Value
20.64 CNY
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
76.1 %
Dividend Yield
–
Gross Profit TTM
-184 244 513 CNY
Earnings per share
-3.53 CNY
Diluted Eps TTM
-3.53 CNY
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-96.2 %
Dividend Analytics 6185
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
-22 %Dividend History 6185
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
23.08.2022
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation 6185
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
15.6086
Price Sales TTM
14.4672
Enterprise Value EBITDA
-3.9431
Price Book MRQ
3.0059
Financials 6185
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 6185
For 52 weeks
37.23 CNY
87.76 CNY
50 Day MA
48.24 CNY
Shares Short Prior Month
–
200 Day MA
49.28 CNY
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart